Health AI Register Logo
ProductsPlatformsCompaniesNewsContact
Productsicolung

Vendor source

Reviewed 11 May 2026

Completeness Strong (75%)

icolung

icometrix

icolung is a cloud-based AI software to quantify the degree of lung involvement in COVID-19 patients. CE cleared, in the US available for clinical use during public health emergency related to COVID-19.

icolung provides the quantification of lung pathology in COVID-19 patients.
- Automated quantification
- Assessment of lesion burden
- Total and regional volumetrics in 6 pulmonary regions
- Quantification per type of CT finding (e.g. GGO, …)

Supported by 1 paper

icolung

Key Features

  • Lesion classification
  • Quantification of lung involvement
  • Total and lobular

General Information

Product name

icolung

Company

Modality

CT

Main task

Not specified

Subspeciality

Chest

Disease targeted

COVID-19

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

Technical Specifications

Patient population age

Not specified

Input

non-contrast chest CT image

Input format

DICOM

Output

Color-coded segmentation overlays, report with quantification of lung involvement.

Output format

DICOM

Integration

Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform

Deployment

Cloud-based

Trigger for analysis

Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload

Processing time

1 - 10 minutes

Population

All non-contrast chest CT images

Market Presence

On market since

04-2020

Resellers

Not specified

Countries present

17

Paying clinical customers

75

Research/test users

20

Pricing Information

Pricing model

Pro bono

Based on

Public need

Source: Vendor | First published: Jun 9, 2024 | Last updated: May 11, 2026